Insiders · Profile

Marcus Ronald

Chief Medical Officer at Avalo Therapeutics. Filing since 20 Oct 2015. CIK 0001653237

Company

Date

Role

Action

Shares

Amount

Of holding

AVTX Avalo Therapeutics, Inc.

20 Oct 2015

Chief Medical Officer

Bought

30,617

no price

569%

1 decision on file.